OGI vs. CMED, WEED, EMC, ICC, LEAF, MGW, BE, BLO, SL, and MJN
Should you be buying Organigram stock or one of its competitors? The main competitors of Organigram include CanniMed Therapeutics (CMED), Canopy Growth (WEED), Emblem (EMC), ICC Labs (ICC), Leaf Mobile (LEAF), Maple Leaf Green World (MGW), Beleave (BE), Cannabix Technologies (BLO), Supreme Cannabis Company Inc, (SL), and Cronos Group (MJN). These companies are all part of the "cannabis" industry.
Organigram vs. Its Competitors
CanniMed Therapeutics (TSE:CMED) and Organigram (TSE:OGI) are both small-cap cannabis companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, dividends, media sentiment and analyst recommendations.
CanniMed Therapeutics has a net margin of 0.00% compared to Organigram's net margin of -31.69%. CanniMed Therapeutics' return on equity of 0.00% beat Organigram's return on equity.
In the previous week, Organigram had 2 more articles in the media than CanniMed Therapeutics. MarketBeat recorded 2 mentions for Organigram and 0 mentions for CanniMed Therapeutics. Organigram's average media sentiment score of 0.32 beat CanniMed Therapeutics' score of 0.00 indicating that Organigram is being referred to more favorably in the news media.
CanniMed Therapeutics has higher earnings, but lower revenue than Organigram.
Organigram has a consensus target price of C$3.33, suggesting a potential upside of 25.95%. Given Organigram's stronger consensus rating and higher possible upside, analysts clearly believe Organigram is more favorable than CanniMed Therapeutics.
4.0% of Organigram shares are owned by institutional investors. 31.3% of Organigram shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Summary
Organigram beats CanniMed Therapeutics on 8 of the 11 factors compared between the two stocks.
Get Organigram News Delivered to You Automatically
Sign up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding OGI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Organigram Competitors List
Related Companies and Tools
This page (TSE:OGI) was last updated on 10/6/2025 by MarketBeat.com Staff
